Intel's weak EPS, declining margins, and uncertain 14A demand highlight its struggles amid cost cuts and capex trims.

Intel posts strong earnings; markets unfazed. Discover why experts rate it a buy & key metrics like cash flows and margins to ...

Today, heavy unusual trading in Intel put options that are out-of-the-money (OTM) could spell trouble for INTC stock over the ...

The return of widespread meme-stock trading coincides with a rise in Goldman Sachs' "Speculative Trading Indicator," which currently sits at its highest level outside of the 1998-to-2001 and ...

Intel Corp shares tanked on Friday after disappointing Q2 earnings. Analysts have mixed views on the company's ...

"During the last 35 years, other sharp increases in speculative trading activity have signaled above-average subsequent 3-, 6-, and 12-month S&P 500 returns, but returns typically faltered on a ...

Wall Street is waking up to a mixed market mood this Friday as U.S. stock futures edge higher, with the Dow Jones and S&P 500 inching closer to fresh record highs. The Nasdaq, however, is under ...

BMNR Stock - Bitmine launches options trading on NYSE, aims to expand crypto footprint with Bitcoin mining and aggressive ...

From the contenders to the rebuilders, here's what every front office is thinking ahead of the July 31 deadline.

Fintel reports that on July 18, 2025, Maxim Group initiated coverage of Akari Therapeutics, Plc - Depositary Receipt () ...

Fintel reports that on July 16, 2025, HC Wainwright & Co. downgraded their outlook for Karyopharm Therapeutics (NasdaqGS:KPTI) from Buy to Neutral. Analyst Price Forecast Suggests 695.59% Upside As of ...